Back to Search Start Over

High-density lipoprotein subfractions and carotid plaque: the Northern Manhattan Study.

Authors :
Tiozzo E
Gardener H
Hudson BI
Dong C
Della-Morte D
Crisby M
Goldberg RB
Elkind MS
Cheung YK
Wright CB
Sacco RL
Rundek T
Source :
Atherosclerosis [Atherosclerosis] 2014 Nov; Vol. 237 (1), pp. 163-8. Date of Electronic Publication: 2014 Sep 09.
Publication Year :
2014

Abstract

Objective: The objective of this cross-sectional analysis was to investigate the relation between two major high-density lipoprotein cholesterol (HDL-C) subfractions (HDL2-C and HDL3-C) and carotid plaque in a population based cohort.<br />Methods: We evaluated 988 stroke-free participants (mean age 66 ± 8 years; 40% men; 66% Hispanic and 34% Non-Hispanic) with available data on HDL subfractions using precipitation method and carotid plaque area and thickness assessed by a high-resolution 2D ultrasound. The associations between HDL-C subfractions and plaque measurements were analyzed by quantile regression.<br />Results: Plaque was present in 56% of the study population. Among those with plaque, the mean ± SD plaque area was 19.40 ± 20.46 mm² and thickness 2.30 ± 4.45 mm. The mean ± SD total HDL-C was 46 ± 14 mg/dl, HDL2-C 14 ± 8 mg/dl, and HDL3-C 32 ± 8 mg/dl. After adjusting for demographics and vascular risk factors, there was an inverse association between HDL3-C and plaque area (per mg/dl: beta = -0.26 at the 75th percentile, p = 0.001 and beta = -0.32 at the 90th percentile, p = 0.02). A positive association was observed between HDL2-C and plaque thickness (per mg/dl; beta = 0.02 at the 90% percentile, p = 0.003). HDL-C was associated with plaque area (per mg/dl: beta = -0.18 at the 90th percentile, p = 0.01), but only among Hispanics.<br />Conclusion: In our cohort we observed an inverse association between HDL3-C and plaque area and a positive association between HDL2-C and plaque thickness. HDL-C subfractions may have different contributions to the risk of vascular disease. More studies are needed to fully elucidate HDL-C anti-atherosclerotic functions in order to improve HDL-based treatments in prevention of vascular disease and stroke.<br /> (Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1879-1484
Volume :
237
Issue :
1
Database :
MEDLINE
Journal :
Atherosclerosis
Publication Type :
Academic Journal
Accession number :
25240111
Full Text :
https://doi.org/10.1016/j.atherosclerosis.2014.09.002